Novel 4-(4-substituted-thiazol-2-ylamino)-N-(pyridin-2-yl)-benzenesulfonamides as cytotoxic and radiosensitizing agents
- 1 January 2012
- journal article
- research article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 35 (1) , 59-68
Abstract
A series of novel 4-(4-substituted-thiazol-2-ylamino)-N-(pyridin-2-yl) benzene-sulfonamides were synthesized and screened for their cytotoxic activity against human breast cancer cell line (MCF-7). Compounds 6, 7, 9, 10, 11, and 14 displayed significant activity against MCF-7 when compared to doxorubicin, which was used as a reference drug. The synergistic effect of Gamma radiation for the most active derivatives 7, 9, and 11 was also studied and their IC50 values markedly decreased to 11.9 μM, 11.7 μM, and 11.6 μM, respectively.Keywords
This publication has 26 references indexed in Scilit:
- Synthesis, antitumor activity and molecular docking study of novel Sulfonamide-Schiff's bases, thiazolidinones, benzothiazinones and their C-nucleoside derivativesEuropean Journal of Medicinal Chemistry, 2010
- Identification of KD5170: A novel mercaptoketone-based histone deacetylase inhibitorBioorganic & Medicinal Chemistry Letters, 2008
- Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scopingBioorganic & Medicinal Chemistry Letters, 2007
- Macrocyclic Aminopyrimidines as Multitarget CDK and VEGF‐R Inhibitors with Potent Antiproliferative ActivitiesChemMedChem, 2006
- Synthesis and evaluation of N-acyl sulfonamides as potential prodrugs of cyclin-dependent kinase inhibitor JNJ-7706621Bioorganic & Medicinal Chemistry Letters, 2006
- The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 StudyClinical Cancer Research, 2006
- Rationale for chemoradiotherapyInternational Journal of Clinical Oncology, 2004
- Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complexNature, 1995
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- N4-Substituted SulfonamidesJournal of the American Chemical Society, 1944